Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arpandev Bhattacharyya

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The National Medical Journal of India|September 26, 2002
Glucose control in hospital: time for an aggressive approachArpandev Bhattacharyya, Vineet Nayyar
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 21, 2016
Clinical Effectiveness and Impact on Insulin Therapy Cost After Addition of Dapagliflozin to Patients with Uncontrolled Type 2 DiabetesBhavana Sosale, Aravind Sosale, Arpandev Bhattacharyya
Indian Journal of Endocrinology and Metabolism|April 25, 2019
Fournier's Gangrene and Sodium-glucose Co-transporter 2(SGLT2) Inhibitors: Our ExperienceAshwitha S Dass, Gloria Immaculate, Arpandev Bhattacharyya
Indian Journal of Endocrinology and Metabolism|April 9, 2013
Thyroid disorders in pregnancyMenaka Ramprasad, Shaila Shamanur Bhattacharyya, Arpandev Bhattacharyya
Indian Journal of Endocrinology and Metabolism|August 22, 2014
Switching from basal or basal-bolus insulin to biphasic insulin aspart 30: Results from the Indian cohort of the A1 chieve studyArpandev Bhattacharyya, Raman Shetty, C Rajkumar, et al.
Indian Journal of Endocrinology and Metabolism|July 25, 2022
Efficacy and Safety of Ultra-Rapid Lispro Versus Lispro in Patients with Type 1 and 2 Diabetes: Indian Subpopulation Analyses of the PRONTO-T1D and PRONTO-T2D TrialsArpandev Bhattacharyya, Indranil Bhattacharya, Vaishali Deshmukh, et al.
The Journal of the Association of Physicians of India|August 31, 2023
Simplifying Type 2 DM Care with Linagliptin: A Position PaperAmbrish Mithal, Ambady Ramachandran, Arpandev Bhattacharyya, et al.
The Journal of the Association of Physicians of India|November 10, 2015
Overview of Clinical Trial Program and Applicability of Insulin Degludec/Insulin Aspart in Diabetes ManagementGanapathi Bantwal, Subhash K Wangnoo, M Shunmugavelu, et al.
Indian Journal of Endocrinology and Metabolism|November 22, 2016
Liraglutide effect and action in diabetes-In (LEAD-In): A prospective observational study assessing safety and effectiveness of liraglutide in patients with type 2 diabetes mellitus treated under routine clinical practice conditions in IndiaSubhash Kumar Wangnoo, Surender Kumar, Arpandev Bhattacharyya, et al.
Indian Journal of Endocrinology and Metabolism|October 2, 2013
Importance of achieving the composite endpoints in diabetesAmbika Gopalakrishnan Unnikrishnan, Arpandev Bhattacharyya, Manash Pratim Baruah, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The National Medical Journal of India|September 26, 2002
Glucose control in hospital: time for an aggressive approachArpandev Bhattacharyya, Vineet Nayyar
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 21, 2016
Clinical Effectiveness and Impact on Insulin Therapy Cost After Addition of Dapagliflozin to Patients with Uncontrolled Type 2 DiabetesBhavana Sosale, Aravind Sosale, Arpandev Bhattacharyya
Indian Journal of Endocrinology and Metabolism|April 25, 2019
Fournier's Gangrene and Sodium-glucose Co-transporter 2(SGLT2) Inhibitors: Our ExperienceAshwitha S Dass, Gloria Immaculate, Arpandev Bhattacharyya
Indian Journal of Endocrinology and Metabolism|April 9, 2013
Thyroid disorders in pregnancyMenaka Ramprasad, Shaila Shamanur Bhattacharyya, Arpandev Bhattacharyya
Indian Journal of Endocrinology and Metabolism|August 22, 2014
Switching from basal or basal-bolus insulin to biphasic insulin aspart 30: Results from the Indian cohort of the A1 chieve studyArpandev Bhattacharyya, Raman Shetty, C Rajkumar, et al.
Indian Journal of Endocrinology and Metabolism|July 25, 2022
Efficacy and Safety of Ultra-Rapid Lispro Versus Lispro in Patients with Type 1 and 2 Diabetes: Indian Subpopulation Analyses of the PRONTO-T1D and PRONTO-T2D TrialsArpandev Bhattacharyya, Indranil Bhattacharya, Vaishali Deshmukh, et al.
The Journal of the Association of Physicians of India|August 31, 2023
Simplifying Type 2 DM Care with Linagliptin: A Position PaperAmbrish Mithal, Ambady Ramachandran, Arpandev Bhattacharyya, et al.
The Journal of the Association of Physicians of India|November 10, 2015
Overview of Clinical Trial Program and Applicability of Insulin Degludec/Insulin Aspart in Diabetes ManagementGanapathi Bantwal, Subhash K Wangnoo, M Shunmugavelu, et al.
Indian Journal of Endocrinology and Metabolism|November 22, 2016
Liraglutide effect and action in diabetes-In (LEAD-In): A prospective observational study assessing safety and effectiveness of liraglutide in patients with type 2 diabetes mellitus treated under routine clinical practice conditions in IndiaSubhash Kumar Wangnoo, Surender Kumar, Arpandev Bhattacharyya, et al.
Indian Journal of Endocrinology and Metabolism|October 2, 2013
Importance of achieving the composite endpoints in diabetesAmbika Gopalakrishnan Unnikrishnan, Arpandev Bhattacharyya, Manash Pratim Baruah, et al.
Pageof 2